Cargando…

Expression of Prostate-specific Membrane Antigen (PSMA) in Papillary Renal Cell Carcinoma - Overview and Report on a Large Multicenter Cohort

Prostate specific membrane antigen (PSMA) is an emerging diagnostic and therapeutic target in prostate cancer. (68)Ga-PSMA-labeled hybrid imaging is used for the detection of prostate primary tumors and metastases. Therapeutic applications such as Lutetium-177 PSMA radionuclide therapy or bispecific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zschäbitz, Stefanie, Erlmeier, Franziska, Stöhr, Christine, Herrmann, Edwin, Polifka, Iris, Agaimy, Abbas, Trojan, Lutz, Ströbel, Philipp, Becker, Frank, Wülfing, Christian, Barth, Peter, Stöckle, Michael, Staehler, Michael, Stief, Christian, Haferkamp, Axel, Hohenfellner, Markus, Macher-Göppinger, Stephan, Wullich, Bernd, Noldus, Joachim, Brenner, Walburgis, Roos, Frederik C., Walter, Bernhard, Otto, Wolfgang, Burger, Maximilian, Schrader, Andres Jan, Mondorf, Yvonne, Hartmann, Arndt, Ivanyi, Philipp, Steffens, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990413/ https://www.ncbi.nlm.nih.gov/pubmed/35399715 http://dx.doi.org/10.7150/jca.63509

Ejemplares similares

Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma
por: Mikuteit, Marie, et al.
Publicado: (2023)

Expression of nectin-4 in papillary renal cell carcinoma
por: Zschäbitz, Stefanie, et al.
Publicado: (2022)

Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma
por: Mikuteit, Marie, et al.
Publicado: (2022)

Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinoma
por: Erlmeier, Maximilian, et al.
Publicado: (2023)

Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients
por: Stöhr, Christine G., et al.
Publicado: (2019)

The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma
por: Weissinger, Daniel, et al.
Publicado: (2013)

Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney
por: Wagener, N, et al.
Publicado: (2007)

Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma
por: Stenzel, Philipp J., et al.
Publicado: (2019)

Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
por: Kahlmeyer, Andreas, et al.
Publicado: (2019)

Profile of temsirolimus in the treatment of advanced renal cell carcinoma
por: Staehler, Michael, et al.
Publicado: (2010)

Liver metastasis of a neuroendocrine tumor demonstrates intense uptake in PSMA-PET—but not its lymph-node metastasis and primary-tumor
por: Winter, Erik, et al.
Publicado: (2023)

Fournier´s Gangrene Under Sodium-Glucose Cotransporter 2 Inhibitor Therapy as a Life-Threatening Adverse Event: A Case Report and Review of the Literature
por: Rodler, Severin, et al.
Publicado: (2019)

Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis
por: Schmidt Hegemann, Nina-Sophie, et al.
Publicado: (2020)

Value of (18)F-PSMA-PET/MRI for Assessment of Recurring Ranula
por: Tilsen, Felix, et al.
Publicado: (2021)

Results from extended lymphadenectomies with [(111)In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
por: Jilg, Cordula A., et al.
Publicado: (2020)

Comparison of isolation platforms for detection of circulating renal cell carcinoma cells
por: Maertens, Yvonne, et al.
Publicado: (2017)

Baseline [(68)Ga]Ga-PSMA-11 PET/CT before [(177)Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions
por: Groener, Daniel, et al.
Publicado: (2023)

Optimized management of urolithiasis by coloured stent-stone contrast using dual-energy computed tomography (DECT)
por: Magistro, Giuseppe, et al.
Publicado: (2019)

Epidemiology and Treatment Barriers of Patients With Erectile Dysfunction Using an Online Prescription Platform: A Cross-Sectional Study
por: Rodler, Severin, et al.
Publicado: (2020)

Prognostic implications of dual tracer PET/CT: PSMA ligand and [(18)F]FDG PET/CT in patients undergoing [(177)Lu]PSMA radioligand therapy
por: Michalski, Kerstin, et al.
Publicado: (2020)

Differences in Distribution and Detection Rate of the [(68)Ga]Ga-PSMA Ligands PSMA-617, -I&T and -11—Inter-Individual Comparison in Patients with Biochemical Relapse of Prostate Cancer
por: Gühne, Falk, et al.
Publicado: (2021)

(18)F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
por: Mittlmeier, L. M., et al.
Publicado: (2020)

Insulin‐like growth factor 2 expression in prostate cancer is regulated by promoter‐specific methylation
por: Küffer, Stefan, et al.
Publicado: (2018)

(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors
por: Gourni, Eleni, et al.
Publicado: (2015)

Total Tumor Volume on (18)F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with (225)Ac-PSMA-I&T
por: Unterrainer, Lena M., et al.
Publicado: (2022)

The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
por: Eder, Ann-Christin, et al.
Publicado: (2021)

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
por: Wagener, Nina, et al.
Publicado: (2010)

Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial
por: Holzgreve, Adrien, et al.
Publicado: (2023)

Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on (18)F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Partial Nephrectomy in pT3a Tumors Less Than 7 cm in Diameter Has a Superior Overall Survival Compared to Radical Nephrectomy
por: Ziegelmueller, Brigitte K, et al.
Publicado: (2019)

Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma
por: Roos, Frederik C, et al.
Publicado: (2014)

Threshold for defining PSMA-positivity prior to (177)Lu-PSMA therapy: a comparison of [(68)Ga]Ga-PSMA-11 and [(18)F]F-DCFPyL in metastatic prostate cancer
por: Heilinger, Jan, et al.
Publicado: (2023)

Multimodal Characterization of a PSMA-Positive Thyroid Nodule Using (68)Ga-PSMA and (124)Iodine PET/US Fusion Imaging
por: Freesmeyer, Martin, et al.
Publicado: (2022)

Impact of [(177)Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [(68)Ga]Ga-PSMA-11-PET/CT
por: Groener, Daniel, et al.
Publicado: (2023)

Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2017)

Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
por: Eckstein, Markus, et al.
Publicado: (2018)

Preclinical comparative study of [(18)F]AlF-PSMA-11 and [(18)F]PSMA-1007 in varying PSMA expressing tumors
por: Piron, Sarah, et al.
Publicado: (2022)

Mitral Multifocal Papillary Fibroelastoma in a Patient with Aggressive Fibromatosis
por: Müller, Philipp P., et al.
Publicado: (2021)

Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
por: Rogowski, Paul, et al.
Publicado: (2021)

PSMA-positive nodal recurrence in prostate cancer: Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hl9i3q2vs4324flprataglkh95